PIMAVANSERIN TARTRATE

PIMAVANSERIN TARTRATE was reported 57532 times

PIMAVANSERIN TARTRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPEECH-LANGUAGE THERAPY 11 0.6471
1 DEMENTIA WITH LEWY BODIES 453 0.4070
2 OCCUPATIONAL THERAPY 18 0.4000
3 PATIENT ELOPEMENT 113 0.3087
4 NONSPECIFIC REACTION 1159 0.2110
5 DELUSION 2852 0.1834
6 PHYSIOTHERAPY 91 0.1764
7 HALLUCINATION 13278 0.1760
8 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 57 0.1418
9 METABOLIC FUNCTION TEST ABNORMAL 44 0.1337
10 HALLUCINATION, VISUAL 2413 0.1142
11 HALLUCINATION, TACTILE 76 0.1141
12 MEDICAL DEVICE BATTERY REPLACEMENT 13 0.0963
13 BELLIGERENCE 39 0.0907
14 CONFUSIONAL AROUSAL 14 0.0870
15 HALLUCINATIONS, MIXED 364 0.0865
16 DEEP BRAIN STIMULATION 48 0.0795
17 DELUSION OF REPLACEMENT 7 0.0700
18 PATIENT UNCOOPERATIVE 33 0.0696
19 FEEDING TUBE USER 25 0.0683
20 PRESCRIBED UNDERDOSE 1193 0.0597
21 POSTURE ABNORMAL 194 0.0596
22 SLEEP TALKING 96 0.0565
23 FREEZING PHENOMENON 195 0.0526
24 DEMENTIA 1461 0.0522
25 DEFIANT BEHAVIOUR 16 0.0519
26 ADULT FAILURE TO THRIVE 11 0.0519
27 MULTIPLE SYSTEM ATROPHY 18 0.0511
28 HALLUCINATION, OLFACTORY 22 0.0506
29 STUBBORNNESS 21 0.0487
30 SOLILOQUY 37 0.0428
31 SUTURE INSERTION 25 0.0427
32 RESTING TREMOR 26 0.0402
33 ABNORMAL BEHAVIOUR 1552 0.0391
34 TRANCE 14 0.0383
35 PARANOIA 655 0.0380
36 MEDICAL DEVICE CHANGE 20 0.0375
37 DREAMY STATE 12 0.0370
38 CATHETER SITE NODULE 7 0.0366
39 DROOLING 241 0.0349
40 DYSGRAPHIA 224 0.0340
41 BRADYKINESIA 200 0.0338
42 ILLUSION 56 0.0338
43 COMMUNICATION DISORDER 127 0.0332
44 HEARING AID USER 14 0.0326
45 SLOW SPEECH 78 0.0321
46 FOOD REFUSAL 28 0.0320
47 SCREAMING 193 0.0303
48 GASTROSTOMY TUBE SITE COMPLICATION 6 0.0300
49 PROGRESSIVE SUPRANUCLEAR PALSY 6 0.0299
50 LIVING IN RESIDENTIAL INSTITUTION 55 0.0293
51 PRODUCT DISTRIBUTION ISSUE 272 0.0293
52 REFUSAL OF TREATMENT BY PATIENT 191 0.0292
53 DELUSIONAL PERCEPTION 12 0.0289
54 STARING 68 0.0281
55 CONFUSIONAL STATE 4448 0.0275
56 TERMINAL STATE 183 0.0273
57 EXPULSION OF MEDICATION 14 0.0265
58 PSEUDOSTROKE 9 0.0262
59 SUSPICIOUSNESS 18 0.0256
60 THERAPEUTIC PRODUCT EFFECT DELAYED 115 0.0252
61 VERBAL ABUSE 12 0.0245
62 SOMATIC DELUSION 6 0.0244
63 SLEEP TERROR 102 0.0242
64 HYPERSOMNIA 690 0.0240
65 SEXUALLY INAPPROPRIATE BEHAVIOUR 11 0.0236
66 AGGRESSION 1180 0.0236
67 REPETITIVE SPEECH 13 0.0231
68 NEURODEGENERATIVE DISORDER 14 0.0227
69 PARKINSONIAN GAIT 14 0.0224
70 HALLUCINATION, AUDITORY 339 0.0213
71 GLASSY EYES 15 0.0212
72 PSYCHOTIC DISORDER 616 0.0208
73 ORTHOSTATIC HYPERTENSION 12 0.0206
74 UNDERDOSE 1502 0.0206
75 BEHAVIOUR DISORDER 110 0.0203
76 INCOHERENT 130 0.0201
77 BLADDER CATHETERISATION 19 0.0196
78 ADVERSE DRUG REACTION 1704 0.0190
79 DISCONTINUED PRODUCT ADMINISTERED 6 0.0182
80 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 9 0.0179
81 LOGORRHOEA 63 0.0179
82 MOTOR DYSFUNCTION 181 0.0177
83 NIGHTMARE 603 0.0174
84 WHEELCHAIR USER 77 0.0173
85 GAIT INABILITY 577 0.0172
86 FEAR OF FALLING 14 0.0172
87 FAILURE TO THRIVE 88 0.0169
88 IMMOBILE 74 0.0169
89 HIP FRACTURE 545 0.0169
90 HOSPICE CARE 166 0.0168
91 OESOPHAGEAL MOTILITY DISORDER 6 0.0167
92 DIET REFUSAL 12 0.0164
93 DISORGANISED SPEECH 30 0.0163
94 DYSSTASIA 469 0.0160
95 CARDIAC ASSISTANCE DEVICE USER 6 0.0160
96 CARDIAC PACEMAKER REPLACEMENT 7 0.0152
97 PRODUCT DOSE OMISSION ISSUE 4364 0.0148
98 ABNORMAL DREAMS 408 0.0148
99 AGITATION 1083 0.0147
100 ON AND OFF PHENOMENON 79 0.0142
101 INTENTIONAL DOSE OMISSION 405 0.0142
102 RAPID EYE MOVEMENTS SLEEP ABNORMAL 6 0.0142
103 ABULIA 13 0.0141
104 ILL-DEFINED DISORDER 836 0.0137
105 HYPOKINESIA 198 0.0136
106 GASTROINTESTINAL TUBE INSERTION 34 0.0136
107 DECUBITUS ULCER 111 0.0136
108 REHABILITATION THERAPY 52 0.0134
109 SPEECH DISORDER 689 0.0131
110 READING DISORDER 30 0.0131
111 DEATH 11261 0.0131
112 STOMA SITE IRRITATION 7 0.0129
113 SHOULDER FRACTURE 21 0.0128
114 PERSECUTORY DELUSION 32 0.0128
115 PSYCHOTIC BEHAVIOUR 13 0.0128
116 STOMA SITE HYPERGRANULATION 8 0.0127
117 FALL 4197 0.0126
118 THERAPEUTIC RESPONSE UNEXPECTED 564 0.0126
119 HYPERVIGILANCE 12 0.0124
120 CATATONIA 64 0.0122
121 DISORIENTATION 483 0.0122
122 BALANCE DISORDER 1053 0.0122
123 ABNORMAL SLEEP-RELATED EVENT 16 0.0121
124 FINE MOTOR SKILL DYSFUNCTION 35 0.0121
125 CIRCADIAN RHYTHM SLEEP DISORDER 10 0.0121
126 GAIT DISTURBANCE 2289 0.0119
127 THOUGHT BLOCKING 7 0.0119
128 HYPORESPONSIVE TO STIMULI 14 0.0119
129 COGNITIVE DISORDER 554 0.0119
130 REDUCED FACIAL EXPRESSION 12 0.0118
131 HOSTILITY 30 0.0118
132 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 563 0.0117
133 BLADDER OBSTRUCTION 6 0.0117
134 CRANIOFACIAL FRACTURE 10 0.0117
135 WALKING AID USER 77 0.0117
136 GENERAL SYMPTOM 87 0.0116
137 SELF-DESTRUCTIVE BEHAVIOUR 10 0.0115
138 MOANING 13 0.0114
139 URINARY TRACT INFECTION 1923 0.0113
140 INCONTINENCE 119 0.0112
141 UNRESPONSIVE TO STIMULI 290 0.0112
142 PERSONALITY CHANGE 103 0.0111
143 PERIPHERAL SWELLING 1697 0.0110
144 GASTROSTOMY 17 0.0110
145 HEAD INJURY 340 0.0107
146 ORTHOSTATIC HYPOTENSION 187 0.0107
147 DEREALISATION 23 0.0107
148 MIDDLE INSOMNIA 197 0.0105
149 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 8 0.0105
150 DAYDREAMING 16 0.0104
151 VASCULAR DEMENTIA 9 0.0103
152 PSYCHOTIC SYMPTOM 21 0.0102
153 OBSESSIVE THOUGHTS 18 0.0100
154 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 10 0.0099
155 ANGER 334 0.0099
156 LIBIDO INCREASED 20 0.0099
157 INTENTIONAL UNDERDOSE 72 0.0098
158 ALTERED VISUAL DEPTH PERCEPTION 8 0.0098
159 PRODUCT DOSE OMISSION IN ERROR 274 0.0097
160 HIP SURGERY 52 0.0096
161 THERAPEUTIC PRODUCT EFFECT VARIABLE 37 0.0095
162 RESTLESSNESS 346 0.0094
163 HYPOPHAGIA 241 0.0094
164 INFUSION SITE NODULE 9 0.0094
165 TONGUE MOVEMENT DISTURBANCE 8 0.0093
166 HYPERSEXUALITY 17 0.0093
167 SLOW RESPONSE TO STIMULI 12 0.0093
168 MEMORY IMPAIRMENT 1256 0.0091
169 SOMNAMBULISM 60 0.0091
170 THINKING ABNORMAL 169 0.0091
171 BEDRIDDEN 119 0.0090
172 CERVICAL VERTEBRAL FRACTURE 31 0.0090
173 SALIVA ALTERED 8 0.0089
174 SOMNOLENCE 1793 0.0089
175 STOMA SITE DISCHARGE 24 0.0088
176 BONE CONTUSION 8 0.0087
177 SALIVARY HYPERSECRETION 87 0.0087
178 PNEUMONIA ASPIRATION 216 0.0086
179 PRODUCT USE ISSUE 1619 0.0086
180 EMERGENCY CARE 26 0.0086
181 CONDITION AGGRAVATED 2605 0.0086
182 STOMA SITE INFECTION 11 0.0084
183 DELIRIUM 291 0.0084
184 CANCER SURGERY 8 0.0084
185 STOMA SITE PAIN 12 0.0082
186 STERNAL FRACTURE 10 0.0081
187 ASPIRATION 88 0.0080
188 MUSCLE RIGIDITY 96 0.0080
189 PRODUCT USE COMPLAINT 126 0.0080
190 METABOLIC ENCEPHALOPATHY 24 0.0080
191 DYSPHAGIA 759 0.0080
192 MULTIPLE DRUG THERAPY 6 0.0080
193 PRESCRIBED OVERDOSE 154 0.0080
194 PRODUCT DOSE OMISSION 519 0.0079
195 TREMOR 1305 0.0079
196 FAECALOMA 43 0.0078
197 CLAVICLE FRACTURE 30 0.0078
198 DISTRACTIBILITY 9 0.0078
199 FLAT AFFECT 18 0.0078
200 SEIZURE LIKE PHENOMENA 13 0.0077
201 SLUGGISHNESS 78 0.0076
202 EYE CONTUSION 16 0.0076
203 THERAPEUTIC PRODUCT EFFECT DECREASED 334 0.0074
204 SKIN LACERATION 81 0.0074
205 SEDATION 191 0.0073
206 LETHARGY 418 0.0073
207 STARVATION 6 0.0072
208 POOR QUALITY SLEEP 155 0.0072
209 FRUSTRATION TOLERANCE DECREASED 58 0.0072
210 DEVICE ALARM ISSUE 13 0.0072
211 DIZZINESS POSTURAL 69 0.0071
212 BLOOD PRESSURE ABNORMAL 141 0.0071
213 PSYCHOMOTOR HYPERACTIVITY 117 0.0070
214 DYSKINESIA 285 0.0070
215 SKIN ABRASION 33 0.0070
216 STOMA SITE ERYTHEMA 13 0.0070
217 MOBILITY DECREASED 499 0.0069
218 JUDGEMENT IMPAIRED 10 0.0069
219 DRUG EFFECT LESS THAN EXPECTED 102 0.0069
220 CARDIAC PACEMAKER INSERTION 41 0.0069
221 LIP INJURY 9 0.0069
222 TERMINAL INSOMNIA 12 0.0068
223 CONSTIPATION 1477 0.0068
224 PRE-EXISTING CONDITION IMPROVED 42 0.0067
225 APHASIA 201 0.0066
226 PROSTATIC OPERATION 8 0.0066
227 PROSTATOMEGALY 26 0.0066
228 FLUID INTAKE REDUCED 33 0.0066
229 OEDEMA PERIPHERAL 802 0.0066
230 HYPERPHAGIA 26 0.0065
231 CATHETER PLACEMENT 12 0.0065
232 RIB FRACTURE 133 0.0065
233 ANAL INCONTINENCE 58 0.0064
234 CRITICAL ILLNESS 5 0.0064
235 GENERAL PHYSICAL HEALTH DETERIORATION 737 0.0064
236 STEREOTYPY 6 0.0064
237 FOREIGN BODY IN THROAT 20 0.0063
238 PRODUCT SUPPLY ISSUE 45 0.0063
239 SLEEP DEFICIT 13 0.0061
240 DYSARTHRIA 231 0.0061
241 HAEMATOLOGICAL INFECTION 15 0.0061
242 FACE INJURY 23 0.0061
243 INITIAL INSOMNIA 62 0.0060
244 MENTAL STATUS CHANGES 165 0.0059
245 PELVIC FRACTURE 46 0.0059
246 SLEEP DISORDER 402 0.0057
247 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 15 0.0056
248 FEAR 151 0.0056
249 MOVEMENT DISORDER 180 0.0056
250 CORONAVIRUS INFECTION 37 0.0056
251 MASTICATION DISORDER 17 0.0055
252 INFUSION SITE MASS 6 0.0055
253 THERAPY INTERRUPTED 393 0.0055
254 INFUSION SITE IRRITATION 7 0.0054
255 INSOMNIA 1452 0.0054
256 COLONOSCOPY 12 0.0054
257 ENURESIS 22 0.0054
258 HOSPITALISATION 831 0.0054
259 BLOOD PRESSURE DECREASED 359 0.0054
260 APRAXIA 8 0.0054
261 IMPULSE-CONTROL DISORDER 11 0.0053
262 MENTAL DISORDER 227 0.0052
263 EATING DISORDER 111 0.0052
264 INFUSION SITE INFECTION 12 0.0052
265 BLOOD PRESSURE FLUCTUATION 123 0.0051
266 FEELING DRUNK 38 0.0051
267 DECREASED INTEREST 30 0.0051
268 DRUG INEFFECTIVE 6630 0.0050
269 ANTISOCIAL BEHAVIOUR 5 0.0050
270 MENTAL IMPAIRMENT 120 0.0049
271 FEEDING DISORDER 100 0.0049
272 YAWNING 13 0.0049
273 BLADDER DYSFUNCTION 5 0.0049
274 HYPOACUSIS 208 0.0048
275 WEIGHT BEARING DIFFICULTY 13 0.0048
276 AKINESIA 10 0.0048
277 BRAIN OPERATION 11 0.0048
278 CRYING 175 0.0048
279 MOOD ALTERED 131 0.0048
280 IMPATIENCE 9 0.0048
281 DYSPHEMIA 21 0.0048
282 GENERAL PHYSICAL CONDITION ABNORMAL 32 0.0047
283 CHOKING 91 0.0047
284 STOMA SITE HAEMORRHAGE 7 0.0045
285 FACIAL BONES FRACTURE 16 0.0044
286 BRADYPHRENIA 29 0.0044
287 MANIA 73 0.0044
288 HEAD TITUBATION 6 0.0044
289 PARADOXICAL DRUG REACTION 16 0.0043
290 TACHYPHRENIA 15 0.0043
291 ILLNESS 444 0.0043
292 IMPULSIVE BEHAVIOUR 16 0.0043
293 CATHETER SITE PAIN 11 0.0042
294 HERNIA REPAIR 11 0.0042
295 IMPAIRED DRIVING ABILITY 48 0.0042
296 VOLVULUS 10 0.0042
297 BRAIN FOG 66 0.0042
298 COLON OPERATION 5 0.0042
299 MYOCARDIAL NECROSIS MARKER INCREASED 7 0.0042
300 NOROVIRUS INFECTION 6 0.0042
301 SOCIAL AVOIDANT BEHAVIOUR 24 0.0041
302 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 293 0.0041
303 OBSESSIVE-COMPULSIVE DISORDER 33 0.0041
304 ANAESTHETIC COMPLICATION 11 0.0041
305 ELECTROCARDIOGRAM ABNORMAL 32 0.0041
306 FEELING OF DESPAIR 19 0.0041
307 PSYCHIATRIC SYMPTOM 30 0.0041
308 URINARY INCONTINENCE 120 0.0040
309 NEPHRECTOMY 6 0.0040
310 PARKINSONISM 39 0.0040
311 MUSCULAR WEAKNESS 453 0.0040
312 HEART RATE IRREGULAR 90 0.0040
313 HEART RATE ABNORMAL 22 0.0039
314 COORDINATION ABNORMAL 55 0.0039
315 MUSCLE CONTRACTURE 8 0.0039
316 MACULAR DEGENERATION 47 0.0039
317 DISEASE COMPLICATION 18 0.0039
318 FEELING ABNORMAL 942 0.0039
319 PALLIATIVE CARE 6 0.0039
320 SEDATION COMPLICATION 10 0.0039
321 MONOPARESIS 7 0.0039
322 WRIST FRACTURE 46 0.0038
323 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 690 0.0038
324 STUPOR 12 0.0037
325 DISTURBANCE IN ATTENTION 200 0.0037
326 SKULL FRACTURE 6 0.0037
327 ADVERSE REACTION 49 0.0037
328 LOSS OF CONTROL OF LEGS 14 0.0037
329 UPPER LIMB FRACTURE 73 0.0037
330 EYE INJURY 11 0.0036
331 AMNESIA 235 0.0036
332 CYSTITIS 115 0.0036
333 ELECTRIC SHOCK SENSATION 10 0.0036
334 CATARACT OPERATION 21 0.0035
335 PRODUCT DISPENSING ISSUE 15 0.0035
336 LUMBAR VERTEBRAL FRACTURE 16 0.0035
337 VITAMIN B12 DECREASED 10 0.0035
338 ANXIETY 987 0.0035
339 MOUTH SWELLING 20 0.0035
340 NOCTURIA 42 0.0035
341 PRODUCT CONTAINER SEAL ISSUE 6 0.0034
342 DRUG INTOLERANCE 331 0.0034
343 TREATMENT NONCOMPLIANCE 186 0.0034
344 ENERGY INCREASED 20 0.0034
345 PHYSICAL ASSAULT 7 0.0033
346 WALKING DISABILITY 7 0.0033
347 LISTLESS 11 0.0033
348 BLOOD SODIUM INCREASED 9 0.0033
349 DEPRESSED MOOD 176 0.0033
350 SPINAL OPERATION 41 0.0033
351 JOINT INJURY 71 0.0033
352 ASTHENIA 1249 0.0033
353 MUSCULOSKELETAL STIFFNESS 289 0.0033
354 HEART RATE DECREASED 115 0.0033
355 COVID-19 573 0.0033
356 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 232 0.0033
357 PRODUCT PRESCRIBING ERROR 77 0.0032
358 PANIC REACTION 23 0.0032
359 DEHYDRATION 424 0.0032
360 TONGUE DISORDER 23 0.0032
361 INFECTED SKIN ULCER 6 0.0032
362 SNORING 12 0.0032
363 HYPOPNOEA 11 0.0032
364 PHARYNGEAL SWELLING 31 0.0032
365 APPETITE DISORDER 21 0.0032
366 MECHANICAL VENTILATION 6 0.0032
367 RADIOTHERAPY 6 0.0031
368 PULMONARY THROMBOSIS 34 0.0031
369 HYPERTONIC BLADDER 9 0.0031
370 DIZZINESS 1554 0.0031
371 PANIC ATTACK 113 0.0031
372 PROSTATIC DISORDER 17 0.0031
373 DIPLOPIA 80 0.0031
374 LIMB DISCOMFORT 95 0.0031
375 DEVICE OCCLUSION 43 0.0031
376 PERSONALITY DISORDER 8 0.0031
377 RESPIRATION ABNORMAL 21 0.0030
378 SWOLLEN TONGUE 95 0.0030
379 SHOULDER OPERATION 13 0.0030
380 OESOPHAGEAL PAIN 12 0.0030
381 DEVICE KINK 11 0.0030
382 INFUSION SITE REACTION 9 0.0030
383 PNEUMONIA 974 0.0030
384 NECK SURGERY 7 0.0030
385 CEREBRAL DISORDER 22 0.0030
386 LIMB INJURY 80 0.0029
387 FEELING JITTERY 56 0.0029
388 JOINT DISLOCATION 31 0.0029
389 CLUMSINESS 8 0.0029
390 BLADDER DISORDER 29 0.0029
391 TRANSIENT ISCHAEMIC ATTACK 98 0.0029
392 CHOLECYSTITIS INFECTIVE 8 0.0029
393 SARS-COV-2 TEST POSITIVE 38 0.0029
394 ENDOTRACHEAL INTUBATION 8 0.0029
395 ABASIA 70 0.0028
396 NERVOUSNESS 148 0.0028
397 HAND FRACTURE 20 0.0028
398 BLOOD PRESSURE INCREASED 428 0.0028
399 EXOPHTHALMOS 6 0.0028
400 MALNUTRITION 31 0.0028
401 URINARY RETENTION 92 0.0028
402 LOWER LIMB FRACTURE 52 0.0027
403 LARGE INTESTINAL OBSTRUCTION 6 0.0027
404 HIP ARTHROPLASTY 41 0.0027
405 FEAR OF DEATH 6 0.0027
406 LOSS OF CONSCIOUSNESS 342 0.0027
407 CRANIOCEREBRAL INJURY 8 0.0026
408 REGURGITATION 9 0.0026
409 CARDIAC DISORDER 244 0.0026
410 DIVERTICULITIS 72 0.0026
411 FLUID RETENTION 132 0.0026
412 IRRITABILITY 156 0.0026
413 SEPSIS 289 0.0026
414 CONCUSSION 20 0.0026
415 CONVERSION DISORDER 5 0.0026
416 ADVERSE EVENT 237 0.0026
417 PATELLA FRACTURE 6 0.0026
418 ORAL SURGERY 6 0.0026
419 FEELING OF BODY TEMPERATURE CHANGE 15 0.0026
420 TIBIA FRACTURE 12 0.0026
421 DISEASE PROGRESSION 302 0.0025
422 RESPIRATORY RATE DECREASED 8 0.0025
423 DYSPEPSIA 250 0.0025
424 ELECTROCARDIOGRAM QT PROLONGED 91 0.0025
425 SYMPTOM RECURRENCE 15 0.0025
426 SEIZURE 289 0.0025
427 LIMB OPERATION 12 0.0025
428 DISABILITY 49 0.0025
429 THROAT TIGHTNESS 67 0.0025
430 FACIAL PARALYSIS 21 0.0025
431 COVID-19 PNEUMONIA 29 0.0025
432 CEREBROVASCULAR ACCIDENT 416 0.0025
433 MICTURITION URGENCY 28 0.0024
434 ABDOMINAL DISCOMFORT 411 0.0024
435 ALTERED STATE OF CONSCIOUSNESS 53 0.0024
436 URINARY TRACT DISORDER 11 0.0024
437 CEREBRAL HAEMORRHAGE 87 0.0024
438 PRODUCT RESIDUE PRESENT 13 0.0024
439 UROSEPSIS 22 0.0024
440 DEPRESSION 541 0.0024
441 DEPRESSED LEVEL OF CONSCIOUSNESS 94 0.0024
442 VISUAL IMPAIRMENT 294 0.0024
443 STENT PLACEMENT 19 0.0024
444 DECREASED APPETITE 546 0.0023
445 BOWEL MOVEMENT IRREGULARITY 18 0.0023
446 CARDIAC OPERATION 20 0.0023
447 MOOD SWINGS 74 0.0023
448 CARDIAC FLUTTER 15 0.0023
449 FUNCTIONAL GASTROINTESTINAL DISORDER 8 0.0023
450 BIPOLAR DISORDER 25 0.0023
451 URINE OUTPUT INCREASED 6 0.0023
452 COMPLICATION ASSOCIATED WITH DEVICE 33 0.0023
453 FEMUR FRACTURE 70 0.0023
454 SURGERY 132 0.0022
455 BLOOD POTASSIUM ABNORMAL 6 0.0022
456 COMPRESSION FRACTURE 12 0.0022
457 BRUXISM 12 0.0022
458 DECREASED ACTIVITY 24 0.0022
459 CHOKING SENSATION 12 0.0022
460 TOXIC ENCEPHALOPATHY 11 0.0022
461 AFFECTIVE DISORDER 17 0.0022
462 INCREASED APPETITE 41 0.0021
463 BACK INJURY 23 0.0021
464 MUSCLE DISORDER 17 0.0021
465 PROSTATE CANCER METASTATIC 7 0.0021
466 RESTLESS LEGS SYNDROME 38 0.0021
467 ORAL DISCOMFORT 29 0.0021
468 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
469 INFUSION SITE SWELLING 13 0.0021
470 UNEVALUABLE EVENT 156 0.0021
471 MALAISE 902 0.0021
472 AUTONOMIC NERVOUS SYSTEM IMBALANCE 6 0.0021
473 NEGATIVE THOUGHTS 6 0.0020
474 ACCIDENTAL OVERDOSE 74 0.0020
475 ACUTE PSYCHOSIS 5 0.0020
476 FOOT OPERATION 10 0.0020
477 RETCHING 43 0.0020
478 ACCIDENT 24 0.0020
479 ASTHENOPIA 11 0.0020
480 SECRETION DISCHARGE 25 0.0020
481 ENCEPHALOPATHY 49 0.0020
482 POLLAKIURIA 83 0.0020
483 GALLBLADDER OPERATION 8 0.0020
484 GLAUCOMA 38 0.0020
485 AORTIC ANEURYSM 15 0.0020
486 AMMONIA INCREASED 10 0.0020
487 FRACTURE 37 0.0020
488 SPINAL FRACTURE 39 0.0019
489 LOCALISED INFECTION 47 0.0019
490 KIDNEY INFECTION 38 0.0019
491 COLD SWEAT 34 0.0019
492 SUICIDAL BEHAVIOUR 8 0.0019
493 NEPHROLITHIASIS 88 0.0019
494 INFUSION SITE ERYTHEMA 16 0.0019
495 SCHIZOPHRENIA 23 0.0019
496 BILE DUCT STONE 6 0.0019
497 DRUG INTERACTION 299 0.0019
498 INTESTINAL OBSTRUCTION 71 0.0019
499 EMOTIONAL DISORDER 58 0.0019
500 URINE ODOUR ABNORMAL 11 0.0019
501 HUMERUS FRACTURE 9 0.0019
502 RESPIRATORY FAILURE 136 0.0019
503 CATHETER SITE INFECTION 7 0.0018
504 BACK DISORDER 30 0.0018
505 DRY MOUTH 149 0.0018
506 PRODUCT USE IN UNAPPROVED INDICATION 453 0.0018
507 GASTROENTERITIS VIRAL 33 0.0018
508 FATIGUE 1417 0.0018
509 SCRATCH 19 0.0018
510 ATRIAL FIBRILLATION 175 0.0018
511 NAUSEA 1422 0.0018
512 POST-TRAUMATIC STRESS DISORDER 12 0.0018
513 JOINT SWELLING 216 0.0018
514 POTENTIATING DRUG INTERACTION 6 0.0018
515 THROAT IRRITATION 80 0.0018
516 THERAPEUTIC RESPONSE SHORTENED 59 0.0018
517 DRUG PRESCRIBING ERROR 34 0.0018
518 URINE ABNORMALITY 8 0.0018
519 EYE MOVEMENT DISORDER 12 0.0018
520 NEUROLOGICAL SYMPTOM 10 0.0017
521 CARDIAC FAILURE CONGESTIVE 140 0.0017
522 EYE OPERATION 8 0.0017
523 OVERDOSE 372 0.0017
524 AORTIC STENOSIS 6 0.0017
525 DRUG DOSE OMISSION 284 0.0017
526 HANGOVER 6 0.0017
527 HICCUPS 14 0.0017
528 HYPOTENSION 342 0.0017
529 HYPOTONIA 17 0.0017
530 DYSTONIA 33 0.0017
531 SPINAL STENOSIS 7 0.0017
532 CLOSTRIDIUM DIFFICILE INFECTION 37 0.0017
533 DYSPHONIA 99 0.0017
534 TOOTH EXTRACTION 21 0.0017
535 SUBDURAL HAEMATOMA 24 0.0017
536 OEDEMA 90 0.0017
537 CARDIAC ARREST 137 0.0017
538 WEIGHT DECREASED 463 0.0017
539 SWELLING 155 0.0017
540 TIC 9 0.0016
541 SPONDYLITIS 6 0.0016
542 TONGUE DISCOMFORT 7 0.0016
543 TENSION 10 0.0016
544 HAEMORRHOIDAL HAEMORRHAGE 8 0.0016
545 INCORRECT DOSAGE ADMINISTERED 8 0.0016
546 BODY TEMPERATURE DECREASED 16 0.0016
547 BREATH SOUNDS ABNORMAL 8 0.0016
548 LIP SWELLING 54 0.0016
549 KNEE ARTHROPLASTY 34 0.0016
550 ANEURYSM 8 0.0016
551 THROAT CLEARING 6 0.0016
552 RHINORRHOEA 103 0.0016
553 PRODUCTIVE COUGH 76 0.0016
554 SYNCOPE 159 0.0016
555 THROMBOSIS 127 0.0016
556 TOE AMPUTATION 8 0.0016
557 CONTUSION 151 0.0016
558 FEMORAL NECK FRACTURE 8 0.0016
559 AFFECT LABILITY 15 0.0016
560 TRISMUS 8 0.0015
561 INFECTION 223 0.0015
562 ACCIDENTAL UNDERDOSE 22 0.0015
563 THERAPEUTIC RESPONSE DECREASED 92 0.0015
564 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 26 0.0015
565 CEREBRAL ATROPHY 6 0.0015
566 RENAL DISORDER 70 0.0015
567 BRAIN INJURY 15 0.0015
568 INTRACRANIAL ANEURYSM 6 0.0015
569 INTERNAL HAEMORRHAGE 17 0.0015
570 ANKLE FRACTURE 23 0.0015
571 SEASONAL ALLERGY 21 0.0015
572 ULCER HAEMORRHAGE 10 0.0015
573 PRODUCT LABEL ISSUE 10 0.0015
574 EUPHORIC MOOD 15 0.0015
575 UPPER-AIRWAY COUGH SYNDROME 12 0.0015
576 SCOLIOSIS 9 0.0015
577 GASTROINTESTINAL INFECTION 13 0.0014
578 EXTRASYSTOLES 10 0.0014
579 STAPHYLOCOCCAL INFECTION 47 0.0014
580 KNEE OPERATION 14 0.0014
581 PRODUCT PRESCRIBING ISSUE 31 0.0014
582 THROAT CANCER 6 0.0014
583 MUSCULOSKELETAL DISORDER 27 0.0014
584 DEAFNESS 37 0.0014
585 CHEST PAIN 262 0.0014
586 TENSION HEADACHE 6 0.0014
587 BACTERIAL INFECTION 26 0.0014
588 CARDIAC MURMUR 12 0.0014
589 LACERATION 13 0.0014
590 CORONARY ARTERIAL STENT INSERTION 7 0.0014
591 SPUTUM DISCOLOURED 13 0.0014
592 CELLULITIS 69 0.0014
593 MELANOCYTIC NAEVUS 6 0.0014
594 PRODUCT AVAILABILITY ISSUE 31 0.0014
595 MUSCLE TIGHTNESS 22 0.0014
596 SWELLING FACE 88 0.0014
597 CARDIAC DYSFUNCTION 5 0.0013
598 POLYURIA 11 0.0013
599 MUSCLE ATROPHY 17 0.0013
600 NIGHT SWEATS 43 0.0013
601 HEART RATE INCREASED 132 0.0013
602 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 39 0.0013
603 SPINAL COMPRESSION FRACTURE 11 0.0013
604 BLOOD POTASSIUM DECREASED 40 0.0013
605 CHROMATURIA 30 0.0013
606 EXTRAPYRAMIDAL DISORDER 33 0.0013
607 OROPHARYNGEAL DISCOMFORT 12 0.0013
608 BLOOD SODIUM DECREASED 25 0.0013
609 WOUND 37 0.0013
610 ABNORMAL LOSS OF WEIGHT 9 0.0013
611 FOOT FRACTURE 25 0.0013
612 TROPONIN INCREASED 10 0.0013
613 VERTIGO 80 0.0013
614 PERIPHERAL COLDNESS 18 0.0013
615 ACUTE RESPIRATORY FAILURE 25 0.0013
616 OXYGEN SATURATION DECREASED 73 0.0013
617 HERNIA 25 0.0013
618 SKIN TIGHTNESS 6 0.0013
619 MYOCARDIAL INFARCTION 221 0.0013
620 BLOOD URINE PRESENT 24 0.0013
621 HYPOAESTHESIA ORAL 19 0.0013
622 URINE OUTPUT DECREASED 11 0.0013
623 PARALYSIS 18 0.0013
624 MIOSIS 10 0.0012
625 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 65 0.0012
626 HEAD DISCOMFORT 22 0.0012
627 DEVICE RELATED INFECTION 19 0.0012
628 BLINDNESS 50 0.0012
629 VITREOUS FLOATERS 12 0.0012
630 SMALL INTESTINAL OBSTRUCTION 15 0.0012
631 HYPERHIDROSIS 156 0.0012
632 HYPERVENTILATION 7 0.0012
633 VOMITING 565 0.0012
634 INFLUENZA 134 0.0012
635 BRAIN NEOPLASM 11 0.0012
636 PAROSMIA 9 0.0012
637 HYPOTHERMIA 12 0.0012
638 WRONG PRODUCT ADMINISTERED 8 0.0012
639 OFF LABEL USE 1032 0.0012
640 INSURANCE ISSUE 18 0.0012
641 DEVICE PHYSICAL PROPERTY ISSUE 9 0.0012
642 ODYNOPHAGIA 7 0.0012
643 CARDIAC FAILURE 94 0.0012
644 VITAMIN D DECREASED 10 0.0012
645 APATHY 17 0.0012
646 ACTIVITIES OF DAILY LIVING IMPAIRED 23 0.0012
647 PALPITATIONS 136 0.0012
648 SKIN ULCER 30 0.0012
649 OSTEOMYELITIS 21 0.0012
650 INTESTINAL PERFORATION 13 0.0012
651 LYMPHOEDEMA 8 0.0012
652 EYE DISORDER 38 0.0012
653 PRESYNCOPE 28 0.0012
654 ABDOMINAL PAIN UPPER 236 0.0011
655 EXPIRED PRODUCT ADMINISTERED 38 0.0011
656 NEOPLASM MALIGNANT 76 0.0011
657 ULCER 18 0.0011
658 THERAPY CHANGE 11 0.0011
659 GASTROINTESTINAL DISORDER 100 0.0011
660 PHOTOPSIA 7 0.0011
661 DEVICE DISLOCATION 48 0.0011
662 ARRHYTHMIA 52 0.0011
663 ESCHERICHIA INFECTION 9 0.0011
664 COMA 52 0.0011
665 ORAL DISORDER 8 0.0011
666 HYPERTENSION 231 0.0011
667 MUSCLE TWITCHING 25 0.0011
668 TASTE DISORDER 22 0.0011
669 DRY THROAT 11 0.0011
670 ARTHROPOD BITE 8 0.0011
671 ARTHRITIS INFECTIVE 5 0.0011
672 SUICIDAL IDEATION 98 0.0011
673 EYE INFECTION 12 0.0011
674 HEMIPARESIS 18 0.0011
675 LEUKAEMIA 10 0.0011
676 DYSURIA 39 0.0011
677 PRODUCT DISPENSING ERROR 23 0.0011
678 TENDON RUPTURE 13 0.0011
679 PRODUCT PACKAGING ISSUE 10 0.0011
680 VIRAL INFECTION 35 0.0011
681 GASTROOESOPHAGEAL REFLUX DISEASE 84 0.0010
682 FEELING COLD 29 0.0010
683 SUDDEN DEATH 11 0.0010
684 MUSCULOSKELETAL CHEST PAIN 16 0.0010
685 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 56 0.0010
686 PHARYNGITIS STREPTOCOCCAL 11 0.0010
687 RESPIRATORY ARREST 28 0.0010
688 RESPIRATORY RATE INCREASED 9 0.0010
689 NEUROLEPTIC MALIGNANT SYNDROME 12 0.0010
690 LIGAMENT SPRAIN 10 0.0010
691 LARGE INTESTINE PERFORATION 7 0.0010
692 COLON CANCER 15 0.0010
693 WOUND INFECTION 11 0.0010
694 ROAD TRAFFIC ACCIDENT 42 0.0010
695 SCIATICA 16 0.0010
696 APHONIA 14 0.0010
697 FOOT DEFORMITY 11 0.0010
698 JOINT STIFFNESS 26 0.0010
699 DIALYSIS 14 0.0010
700 TOOTH INFECTION 13 0.0010
701 SUBARACHNOID HAEMORRHAGE 10 0.0010
702 PNEUMONIA BACTERIAL 9 0.0010
703 INCREASED TENDENCY TO BRUISE 9 0.0010
704 SKIN CANCER 21 0.0010
705 IMPAIRED QUALITY OF LIFE 14 0.0010
706 PARAESTHESIA ORAL 14 0.0010
707 VISUAL FIELD DEFECT 7 0.0010
708 VENTRICULAR EXTRASYSTOLES 10 0.0010
709 BRADYCARDIA 51 0.0010
710 DERMATITIS ALLERGIC 12 0.0010
711 PRODUCT PHYSICAL ISSUE 19 0.0009
712 SENSORY DISTURBANCE 15 0.0009
713 DYSPNOEA 527 0.0009
714 COUGH 261 0.0009
715 NERVOUS SYSTEM DISORDER 29 0.0009
716 PULMONARY EMBOLISM 88 0.0009
717 BLISTER 52 0.0009
718 RASH PRURITIC 50 0.0009
719 BLINDNESS UNILATERAL 13 0.0009
720 BACK PAIN 212 0.0009
721 PULMONARY CONGESTION 12 0.0009
722 GRIP STRENGTH DECREASED 8 0.0009
723 RASH 396 0.0009
724 ATRIOVENTRICULAR BLOCK 7 0.0009
725 INTENTIONAL SELF-INJURY 18 0.0009
726 MUSCULOSKELETAL DISCOMFORT 15 0.0009
727 RESPIRATORY DISORDER 26 0.0009
728 INCORRECT DOSE ADMINISTERED 198 0.0009
729 HYPERSENSITIVITY 161 0.0009
730 PERICARDIAL EFFUSION 20 0.0009
731 BRONCHITIS 64 0.0009
732 NEURALGIA 21 0.0009
733 SINUS DISORDER 17 0.0009
734 THERAPY CESSATION 44 0.0009
735 ABNORMAL FAECES 7 0.0009
736 TARDIVE DYSKINESIA 24 0.0008
737 CHEST DISCOMFORT 87 0.0008
738 PULMONARY OEDEMA 38 0.0008
739 ORAL PAIN 19 0.0008
740 PAIN IN EXTREMITY 250 0.0008
741 DIVERTICULUM 6 0.0008
742 ATAXIA 10 0.0008
743 SLEEP APNOEA SYNDROME 16 0.0008
744 CARDIO-RESPIRATORY ARREST 35 0.0008
745 GOUT 15 0.0008
746 HYPOXIA 29 0.0008
747 MALIGNANT MELANOMA 11 0.0008
748 COLITIS 31 0.0008
749 MUSCLE SPASTICITY 10 0.0008
750 NASOPHARYNGITIS 150 0.0008
751 BLOOD MAGNESIUM DECREASED 7 0.0008
752 MUSCLE STRAIN 7 0.0008
753 VISION BLURRED 111 0.0008
754 INABILITY TO AFFORD MEDICATION 8 0.0008
755 DISCOMFORT 49 0.0008
756 DEVICE USE ISSUE 14 0.0008
757 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 162 0.0008
758 BLEPHAROSPASM 5 0.0008
759 PRODUCT ADMINISTRATION ERROR 16 0.0008
760 BLOOD GLUCOSE DECREASED 38 0.0008
761 EAR INFECTION 21 0.0008
762 DIABETES MELLITUS 60 0.0008
763 BODY TEMPERATURE INCREASED 16 0.0008
764 DIARRHOEA 506 0.0008
765 POST PROCEDURAL COMPLICATION 15 0.0008
766 UNINTENTIONAL MEDICAL DEVICE REMOVAL 9 0.0008
767 FREQUENT BOWEL MOVEMENTS 21 0.0008
768 ABDOMINAL DISTENSION 81 0.0008
769 ELECTROLYTE IMBALANCE 9 0.0008
770 PALLOR 21 0.0008
771 TRANSFUSION 8 0.0008
772 CIRCULATORY COLLAPSE 13 0.0008
773 RESPIRATORY DISTRESS 21 0.0008
774 BURNING SENSATION 53 0.0008
775 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
776 GASTROINTESTINAL HAEMORRHAGE 63 0.0008
777 EYE SWELLING 28 0.0008
778 HEADACHE 471 0.0008
779 FEELING HOT 46 0.0007
780 NEPHROPATHY 7 0.0007
781 RENAL FAILURE 99 0.0007
782 ARTERIOSCLEROSIS 7 0.0007
783 MYASTHENIA GRAVIS 6 0.0007
784 SINUS CONGESTION 10 0.0007
785 CATARACT 44 0.0007
786 IMPAIRED GASTRIC EMPTYING 10 0.0007
787 TOOTH FRACTURE 8 0.0007
788 DRUG EFFECT DECREASED 39 0.0007
789 FUNGAL INFECTION 24 0.0007
790 TINNITUS 33 0.0007
791 SKIN INFECTION 8 0.0007
792 BRAIN OEDEMA 9 0.0007
793 SCAB 8 0.0007
794 HAEMATURIA 24 0.0007
795 MUSCLE SPASMS 128 0.0007
796 INJURY 49 0.0007
797 EAR DISCOMFORT 7 0.0007
798 HELICOBACTER INFECTION 7 0.0007
799 DEVICE ISSUE 61 0.0007
800 GASTRIC DISORDER 23 0.0007
801 HYPERLIPIDAEMIA 8 0.0007
802 HAEMORRHAGE INTRACRANIAL 10 0.0007
803 EXTRA DOSE ADMINISTERED 27 0.0007
804 WEIGHT INCREASED 148 0.0007
805 AKATHISIA 9 0.0007
806 SKIN DISCOLOURATION 30 0.0007
807 NERVE COMPRESSION 6 0.0006
808 ARTHRITIS 51 0.0006
809 NERVE INJURY 7 0.0006
810 RESPIRATORY TRACT CONGESTION 10 0.0006
811 LACRIMATION INCREASED 19 0.0006
812 EMOTIONAL DISTRESS 76 0.0006
813 UPPER RESPIRATORY TRACT INFECTION 29 0.0006
814 ATRIAL FLUTTER 5 0.0006
815 OROPHARYNGEAL PAIN 58 0.0006
816 NECK PAIN 35 0.0006
817 WHITE BLOOD CELL COUNT INCREASED 24 0.0006
818 HOT FLUSH 47 0.0006
819 ROTATOR CUFF SYNDROME 8 0.0006
820 ANOSMIA 9 0.0006
821 HYPOAESTHESIA 93 0.0006
822 ATELECTASIS 6 0.0006
823 HIATUS HERNIA 8 0.0006
824 HAEMATOMA 16 0.0006
825 GASTROENTERITIS 9 0.0006
826 BLOOD POTASSIUM INCREASED 10 0.0006
827 THIRST 11 0.0006
828 CHOLECYSTECTOMY 7 0.0006
829 ASPHYXIA 5 0.0006
830 MULTIPLE FRACTURES 10 0.0006
831 QUALITY OF LIFE DECREASED 8 0.0006
832 WITHDRAWAL SYNDROME 25 0.0006
833 BLOOD IRON DECREASED 7 0.0006
834 TOOTH ABSCESS 6 0.0006
835 PANCREATIC CARCINOMA 17 0.0006
836 RASH ERYTHEMATOUS 28 0.0006
837 SKIN LESION 16 0.0006
838 TEMPERATURE INTOLERANCE 6 0.0006
839 THERAPY NON-RESPONDER 26 0.0006
840 PAIN 355 0.0006
841 WEIGHT FLUCTUATION 6 0.0006
842 SKIN DISORDER 19 0.0006
843 OCULAR HYPERAEMIA 27 0.0006
844 NEUROPATHY PERIPHERAL 54 0.0006
845 PNEUMOTHORAX 9 0.0006
846 GENERALISED OEDEMA 7 0.0006
847 HERPES ZOSTER 32 0.0006
848 SEPTIC SHOCK 24 0.0006
849 RASH MACULAR 19 0.0005
850 INFUSION SITE PAIN 7 0.0005
851 WHEEZING 32 0.0005
852 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
853 FLATULENCE 30 0.0005
854 CORONARY ARTERY DISEASE 16 0.0005
855 GASTRIC HAEMORRHAGE 6 0.0005
856 PHARYNGEAL OEDEMA 8 0.0005
857 THYROID DISORDER 8 0.0005
858 PRODUCT TASTE ABNORMAL 7 0.0005
859 ERUCTATION 10 0.0005
860 NASAL CONGESTION 30 0.0005
861 BACTERAEMIA 6 0.0005
862 MASS 7 0.0005
863 TOOTHACHE 9 0.0005
864 TOOTH DISORDER 11 0.0005
865 PLEURAL EFFUSION 30 0.0005
866 SNEEZING 11 0.0005
867 BLOOD GLUCOSE ABNORMAL 9 0.0005
868 LUNG NEOPLASM MALIGNANT 20 0.0005
869 PROSTATE CANCER 39 0.0005
870 TOOTH LOSS 10 0.0005
871 CANDIDA INFECTION 8 0.0005
872 CARDIOMYOPATHY 7 0.0005
873 ARTHROPATHY 26 0.0005
874 BODY HEIGHT DECREASED 5 0.0005
875 HEPATIC FAILURE 14 0.0005
876 PARAESTHESIA 73 0.0005
877 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
878 RESPIRATORY TRACT INFECTION 12 0.0005
879 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
880 BLOOD GLUCOSE FLUCTUATION 5 0.0005
881 EPISTAXIS 34 0.0005
882 RECTAL HAEMORRHAGE 19 0.0004
883 SKIN EXFOLIATION 37 0.0004
884 PROSTATIC SPECIFIC ANTIGEN INCREASED 6 0.0004
885 RHABDOMYOLYSIS 18 0.0004
886 HUNGER 6 0.0004
887 BLOOD TEST ABNORMAL 6 0.0004
888 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
889 PRURITUS 161 0.0004
890 HEPATIC CANCER 10 0.0004
891 DRUG EFFECT INCOMPLETE 15 0.0004
892 HAEMORRHAGE 43 0.0004
893 ARTHRALGIA 170 0.0004
894 MIGRAINE 39 0.0004
895 SKIN HAEMORRHAGE 6 0.0004
896 DYSGEUSIA 30 0.0004
897 AGEUSIA 10 0.0004
898 SINUSITIS 41 0.0004
899 HAEMATOCHEZIA 22 0.0004
900 ABDOMINAL PAIN LOWER 10 0.0004
901 ERYTHEMA 81 0.0004
902 URTICARIA 66 0.0004
903 CARDIOVASCULAR DISORDER 10 0.0004
904 BLOOD GLUCOSE INCREASED 74 0.0004
905 GALLBLADDER DISORDER 7 0.0004
906 PYREXIA 134 0.0004
907 DEEP VEIN THROMBOSIS 25 0.0004
908 FLUSHING 38 0.0004
909 GASTRIC ULCER 7 0.0004
910 SEROTONIN SYNDROME 7 0.0004
911 NO ADVERSE EVENT 66 0.0004
912 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 17 0.0004
913 SUICIDE ATTEMPT 22 0.0004
914 DRY EYE 18 0.0004
915 HAEMORRHOIDS 7 0.0004
916 DEVICE DIFFICULT TO USE 23 0.0003
917 OSTEOPOROSIS 14 0.0003
918 CHOLELITHIASIS 11 0.0003
919 IMPAIRED HEALING 11 0.0003
920 RENAL IMPAIRMENT 28 0.0003
921 CHILLS 39 0.0003
922 BLOOD COUNT ABNORMAL 5 0.0003
923 EYE PRURITUS 11 0.0003
924 LUNG DISORDER 16 0.0003
925 FAECES DISCOLOURED 7 0.0003
926 BLOOD CHOLESTEROL INCREASED 15 0.0003
927 BASAL CELL CARCINOMA 5 0.0003
928 DEVICE BREAKAGE 13 0.0003
929 HAEMATEMESIS 8 0.0003
930 ABSCESS 5 0.0003
931 ACUTE MYOCARDIAL INFARCTION 9 0.0003
932 EYE IRRITATION 17 0.0003
933 INFLAMMATION 15 0.0003
934 MYALGIA 49 0.0003
935 PULMONARY HYPERTENSION 6 0.0003
936 ANAEMIA 54 0.0003
937 PAIN IN JAW 8 0.0003
938 PLASMA CELL MYELOMA 11 0.0003
939 INTENTIONAL OVERDOSE 18 0.0003
940 IRRITABLE BOWEL SYNDROME 6 0.0003
941 INFLUENZA LIKE ILLNESS 23 0.0003
942 ABDOMINAL PAIN 64 0.0003
943 BONE DISORDER 5 0.0003
944 LABORATORY TEST ABNORMAL 8 0.0003
945 VISUAL ACUITY REDUCED 9 0.0003
946 DRY SKIN 36 0.0003
947 GASTRITIS 7 0.0003
948 OSTEOARTHRITIS 11 0.0003
949 ACUTE KIDNEY INJURY 39 0.0003
950 HAEMOGLOBIN DECREASED 26 0.0003
951 HAEMOPTYSIS 7 0.0003
952 CHRONIC KIDNEY DISEASE 19 0.0002
953 ALOPECIA 49 0.0002
954 ANGIOEDEMA 11 0.0002
955 LIVER DISORDER 11 0.0002
956 ANGINA PECTORIS 7 0.0002
957 SKIN BURNING SENSATION 17 0.0002
958 DEVICE LEAKAGE 10 0.0002
959 DEVICE USE ERROR 8 0.0002
960 PAIN OF SKIN 6 0.0002
961 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
962 SKIN IRRITATION 10 0.0002
963 PROCEDURAL PAIN 6 0.0002
964 EYE PAIN 12 0.0002
965 BLADDER CANCER 12 0.0002
966 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
967 EPILEPSY 6 0.0002
968 HYPERGLYCAEMIA 7 0.0002
969 COMPLETED SUICIDE 16 0.0002
970 TACHYCARDIA 17 0.0002
971 APPLICATION SITE ERYTHEMA 5 0.0002
972 ANHEDONIA 5 0.0002
973 HYPOGLYCAEMIA 9 0.0002
974 TYPE 2 DIABETES MELLITUS 6 0.0002
975 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
976 ASTHMA 20 0.0002
977 ECZEMA 9 0.0002
978 PRODUCT STORAGE ERROR 14 0.0002
979 INTENTIONAL PRODUCT MISUSE 14 0.0002
980 MUSCULOSKELETAL PAIN 8 0.0002
981 BREAST CANCER 14 0.0002
982 STOMATITIS 8 0.0001
983 HYPOKALAEMIA 6 0.0001
984 HYPONATRAEMIA 7 0.0001
985 BONE PAIN 7 0.0001
986 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
987 DEVICE MALFUNCTION 8 0.0001
988 PANCREATITIS 6 0.0001
989 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
990 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
991 INJECTION SITE ERYTHEMA 10 0.0001
992 PLATELET COUNT DECREASED 7 0.0001
993 PSORIASIS 8 0.0001